Breast Cancer Trial, Recruiting NCT06006806 Sponsor: Covenant Health Cancer Center Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06006806
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing to participate and have signed an approved consent form
  • People who are 18 years of age or older
  • People who have been diagnosed with stage 0, I, II, or III breast cancer
  • People whose tumor has been identified under a microscope as either ductal carcinoma in situ (DCIS) or a type of invasive breast cancer called invasive adenocarcinoma
  • People who have already had surgery for breast cancer, either a lumpectomy (removal of the tumor) or a mastectomy (removal of the breast)
  • People who have had a test done on their tumor to check for estrogen receptors
  • People whose doctor has determined that no serious health conditions are present that could affect their ability to complete treatment or affect the skin in the area being treated
  • A progesterone receptor test on the tumor is preferred but not required

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People diagnosed with stage IV (advanced/metastatic) breast cancer
  • People whose breast cancer is a non-common type such as sarcoma or lymphoma
  • People diagnosed with Paget's disease of the nipple
  • People who have previously received radiation therapy to the breast or chest area for any reason
  • People with certain connective tissue or autoimmune conditions, including dermatomyositis (with abnormal muscle enzyme levels or an active skin rash), lupus, or scleroderma
  • People who are currently pregnant or breastfeeding
  • People with psychiatric conditions, addiction disorders, or other conditions that the trial investigators believe would prevent them from completing the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Samantha Hedrick, PhD, Director of Medical Physics

Phone: 865-862-1600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Covenant Health Cancer Center
Registry
ClinicalTrials.gov
Start date
7 July 2023
Est. completion
7 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reduction in Radiation Dermatitis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov